Juli Liu

986 total citations
23 papers, 636 citations indexed

About

Juli Liu is a scholar working on Molecular Biology, Infectious Diseases and Cancer Research. According to data from OpenAlex, Juli Liu has authored 23 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Cancer Research. Recurrent topics in Juli Liu's work include SARS-CoV-2 and COVID-19 Research (7 papers), MicroRNA in disease regulation (4 papers) and COVID-19 Clinical Research Studies (3 papers). Juli Liu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), MicroRNA in disease regulation (4 papers) and COVID-19 Clinical Research Studies (3 papers). Juli Liu collaborates with scholars based in China and United States. Juli Liu's co-authors include Lei Yang, Xi‐Yong Yu, Qiu‐Xiong Lin, Lin Shu-guang, Liping Mai, Zhi‐Xin Shan, Jie-Ning Zhu, Xiaoying Liu, Yong‐Heng Fu and Chunyu Deng and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Development.

In The Last Decade

Juli Liu

23 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juli Liu China 13 422 215 91 63 50 23 636
Wenguang Wang China 15 279 0.7× 108 0.5× 40 0.4× 52 0.8× 37 0.7× 55 653
Sheng Yao China 14 283 0.7× 52 0.2× 57 0.6× 50 0.8× 35 0.7× 37 641
Haiyang Xu China 17 573 1.4× 293 1.4× 22 0.2× 18 0.3× 42 0.8× 31 899
Muralidhara Padigaru Türkiye 14 228 0.5× 106 0.5× 20 0.2× 53 0.8× 22 0.4× 43 473
Xiaodan Zhong China 18 397 0.9× 159 0.7× 27 0.3× 54 0.9× 10 0.2× 46 714
Huizhen Wang China 13 248 0.6× 105 0.5× 22 0.2× 53 0.8× 20 0.4× 38 562
Yilan Huang China 13 235 0.6× 61 0.3× 22 0.2× 32 0.5× 28 0.6× 40 505
Liyun Liu China 15 290 0.7× 59 0.3× 18 0.2× 34 0.5× 19 0.4× 42 598
Seyed Rouhollah Miri Iran 10 315 0.7× 113 0.5× 40 0.4× 9 0.1× 17 0.3× 18 631
Youting Chen China 13 225 0.5× 41 0.2× 75 0.8× 14 0.2× 18 0.4× 32 514

Countries citing papers authored by Juli Liu

Since Specialization
Citations

This map shows the geographic impact of Juli Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juli Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juli Liu more than expected).

Fields of papers citing papers by Juli Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juli Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juli Liu. The network helps show where Juli Liu may publish in the future.

Co-authorship network of co-authors of Juli Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Juli Liu. A scholar is included among the top collaborators of Juli Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juli Liu. Juli Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Juli, et al.. (2024). Trisomy 21-driven metabolite alterations are linked to cellular injuries in Down syndrome. Cellular and Molecular Life Sciences. 81(1). 1 indexed citations
2.
Chen, Shaoxian, et al.. (2024). Monkeypox virus protein H3L induces injuries in human and mouse. Cell Death and Disease. 15(8). 607–607. 1 indexed citations
3.
Cui, Yongde, Juli Liu, Xin Qi, et al.. (2024). Single‐Cell RNA‐Seq Reveals Injuries in Aortic Dissection and Identifies PDGF Signalling Pathway as a Potential Therapeutic Target. Journal of Cellular and Molecular Medicine. 28(24). e70293–e70293. 3 indexed citations
4.
Liu, Juli, Shiyong Wu, Yucheng Zhang, et al.. (2023). SARS-CoV-2 viral genes Nsp6, Nsp8, and M compromise cellular ATP levels to impair survival and function of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Research & Therapy. 14(1). 249–249. 4 indexed citations
5.
Hong, Yimei, Cong Mai, Zicong Wu, et al.. (2023). Transcriptome analysis reveals therapeutic potential of NAMPT in protecting against abdominal aortic aneurysm in human and mouse. Bioactive Materials. 34. 17–36. 8 indexed citations
6.
Liu, Juli, Yucheng Zhang, Lei Han, et al.. (2022). Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral gene Orf9c on human pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports. 17(3). 522–537. 5 indexed citations
7.
Fang, Shuyi, Sheng Liu, Jikui Shen, et al.. (2021). Updated SARS‐CoV‐2 single nucleotide variants and mortality association. Journal of Medical Virology. 93(12). 6525–6534. 13 indexed citations
8.
Liu, Juli, Sheng Liu, Lei Han, et al.. (2021). LncRNA HBL1 is required for genome-wide PRC2 occupancy and function in cardiogenesis from human pluripotent stem cells. Development. 148(13). 15 indexed citations
9.
Liu, Sheng, Jikui Shen, Shuyi Fang, et al.. (2020). Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2. Publisher. 3 indexed citations
10.
Fang, Shuyi, Kailing Li, Jikui Shen, et al.. (2020). GESS: a database of global evaluation of SARS-CoV-2/hCoV-19 sequences. Publisher. 2 indexed citations
11.
Chen, Shaoxian, et al.. (2020). Global gene expression analysis using RNA-seq reveals the new roles of Panax notoginseng Saponins in ischemic cardiomyocytes. Journal of Ethnopharmacology. 268. 113639–113639. 19 indexed citations
12.
Liu, Sheng, Jikui Shen, Shuyi Fang, et al.. (2020). Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2. Frontiers in Microbiology. 11. 593548–593548. 36 indexed citations
13.
Liu, Juli, Sheng Liu, Hongyu Gao, et al.. (2020). Genome-wide studies reveal the essential and opposite roles of ARID1A in controlling human cardiogenesis and neurogenesis from pluripotent stem cells. Genome biology. 21(1). 169–169. 31 indexed citations
14.
Wu, Wei, Juli Liu, Zhenghui Su, et al.. (2018). Generation of H1 PAX6 WT/EGFP reporter cells to purify PAX6 positive neural stem/progenitor cells. Biochemical and Biophysical Research Communications. 502(4). 442–449. 2 indexed citations
15.
Liu, Juli, Yang Li, Bo Lin, Sheng Yi, & Lei Yang. (2017). HBL1 Is a Human Long Noncoding RNA that Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1. Developmental Cell. 42(4). 333–348.e5. 53 indexed citations
16.
Chen, Shaoxian, Juli Liu, Min Yang, et al.. (2015). Fn14, a Downstream Target of the TGF-β Signaling Pathway, Regulates Fibroblast Activation. PLoS ONE. 10(12). e0143802–e0143802. 21 indexed citations
17.
Liu, Juli, Li Jiang, Qiu‐Xiong Lin, et al.. (2012). MicroRNA 16 enhances differentiation of human bone marrow mesenchymal stem cells in a cardiac niche toward myogenic phenotypes in vitro. Life Sciences. 90(25-26). 1020–1026. 27 indexed citations
18.
Chen, Shaoxian, Juli Liu, Xiaoying Liu, et al.. (2011). Panax notoginseng saponins inhibit ischemia-induced apoptosis by activating PI3K/Akt pathway in cardiomyocytes. Journal of Ethnopharmacology. 137(1). 263–270. 97 indexed citations
19.
Shan, Zhi‐Xin, Qiu‐Xiong Lin, Min Yang, et al.. (2010). Transcription factor Ap-1 mediates proangiogenic MIF expression in human endothelial cells exposed to Angiotensin II. Cytokine. 53(1). 35–41. 10 indexed citations
20.
Shan, Zhi‐Xin, Qiu‐Xiong Lin, Chunyu Deng, et al.. (2010). miR‐1/miR‐206 regulate Hsp60 expression contributing to glucose‐mediated apoptosis in cardiomyocytes. FEBS Letters. 584(16). 3592–3600. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenguang Wang Breakdown of academic impact, for papers by Sheng Yao Breakdown of academic impact, for papers by Haiyang Xu Breakdown of academic impact, for papers by Muralidhara Padigaru Breakdown of academic impact, for papers by Xiaodan Zhong Breakdown of academic impact, for papers by Huizhen Wang Breakdown of academic impact, for papers by Yilan Huang Breakdown of academic impact, for papers by Liyun Liu Breakdown of academic impact, for papers by Seyed Rouhollah Miri Breakdown of academic impact, for papers by Youting Chen
Rankless by CCL
2026